BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26189249)

  • 21. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma.
    Koh YW; Park YS; Kang HJ; Shim JH; Yu E
    Tumour Biol; 2015 Jul; 36(7):4993-5000. PubMed ID: 25874493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rap1GAP inhibits tumor progression in endometrial cancer.
    Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
    Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
    Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance.
    Han WL; Li WD; Hu J; Rusidanmu A; Chen LF; Shen L; Zheng SS
    Chin Med J (Engl); 2012 Mar; 125(6):1110-4. PubMed ID: 22613539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
    Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
    BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
    Song H; Li C; Lu R; Zhang Y; Geng J
    Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
    Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
    Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
    Kong Y; Ren Z
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
    Steinbakk A; Malpica A; Slewa A; Skaland I; Gudlaugsson E; Janssen EA; Løvslett K; Fiane B; Kruse AJ; Feng W; Yinhua Y; Baak JP
    Mod Pathol; 2011 Sep; 24(9):1262-71. PubMed ID: 21552210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors].
    Fracchioli S; Katsaros D; Maggiora P; Di Renzo MF; Massobrio M
    Minerva Ginecol; 1999 Oct; 51(10):359-64. PubMed ID: 10638160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
    Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas.
    Köbel M; Langhammer T; Hüttelmaier S; Schmitt WD; Kriese K; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
    Mod Pathol; 2006 Apr; 19(4):581-7. PubMed ID: 16554733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.